| University of Michigan, Bachelor of Science |
Ms. Nancy Stuart has over 20 years of biotechnology and pharmaceutical industry experience and currently serves as Chief Operating Officer of Concert Pharmaceuticals, Inc. Prior to joining Concert in July 2006, she held senior level business and drug development positions at RRD International, Scion Pharmaceuticals, Kinetix/Amgen Inc., Vertex Pharmaceuticals, Inc. and Genzyme Corporation. At Kinetix, Ms. Stuart established the business development strategy that culminated in its $170 million acquisition by Amgen. At Vertex, she served as Vice President of Program Planning and Management and was responsible for Vertex’s strategic partnerships and global drug development programs. In addition, she co-directed the development of Agenerase®, Vertex’s HIV protease inhibitor and initiated the Thyrogen® program for thyroid cancer testing at Genzyme. She has had extensive experience in raising private capital for start up biotechnology companies. Ms. Stuart is a member of the Board of Directors for the YMCA of Greater Boston.
